Filtered By:
Management: Marketing

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 30894 results found since Jan 2013.

Why comply? Risk and efficacy perceptions drive compliance in mass marketing scams
J Elder Abuse Negl. 2023 Apr 11:1-33. doi: 10.1080/08946566.2023.2197268. Online ahead of print.ABSTRACTUsing a mix-method design, we examined participants' willingness to respond to mass marketing scams (MMS). In Experiment 1, we examined the effect of age (young versus older) and letter style ("hot" versus "cold") on the intention to respond. The intention of responding was negatively associated with risk (p < .001) and having at least a high school education was positively associated with perception of benefits (b = .684, p < .001). In Experiment 2, we examined reward sensitivity on the intention to respond by man...
Source: Journal of Elder Abuse and Neglect - April 12, 2023 Category: Geriatrics Authors: Stacey Wood David Hengerer Yaniv Hanoch Pi-Ju Liu Patricia Xi Joshua Paul Lukas Klapatch Source Type: research

All roads lead to the farmers market?: using network analysis to measure the orientation and central actors in a community food system through a case comparison of Yolo and Sacramento County, California
AbstractLittle is known about how farms and markets are connected. Identifying critical gaps and central hubs in food systems is of importance in addressing a variety of concerns, such as navigating rapid shifts in marketing practices as seen during the COVID-19 pandemic and related food shortages. The constellation of growers and markets can also reinforce opportunities to shift growing and eating policies and practices with attention to addressing racial and income inequities in food system ownership and access. With this research, we compare network methods for measuring centrality and sociospatial orientations in food ...
Source: Agriculture and Human Values - August 18, 2022 Category: Food Science Source Type: research

A social marketing perspective of young adults' concepts of eating for health: is it a question of morality?
Poor dietary choices are a risk factor for non-communicable diseases. Young adults have low levels of engagement towards their health and may not see the importance in the adoption of healthy eating behaviours...
Source: International Journal of Behavioral Nutrition and Physical Activity - March 30, 2020 Category: Nutrition Authors: Linda Brennan, Karen Klassen, Enqi Weng, Shinyi Chin, Annika Molenaar, Michael Reid, Helen Truby and Tracy A. McCaffrey Tags: Research Source Type: research

Sexual violence and safety: the narratives of transwomen in online forums - Noack-Lundberg K, Liamputtong P, Marjadi B, Ussher J, Perz J, Schmied V, Dune T, Brook E.
An online forum analysis was conducted to explore experiences of sexual violence and safety among transwomen, with a particular focus on transwomen of colour. Four online forums were chosen for the analysis. Three key themes were identified: dating and vio...
Source: SafetyLit - July 11, 2019 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news

Implementation lessons for school food policies and marketing restrictions in the Philippines: a qualitative policy analysis
The school environment can enhance children ’s skills, knowledge and behaviours in relation to healthy eating. However, in many countries, unhealthy foods are commonly available in schools, and children can be ...
Source: Globalization and Health - January 23, 2018 Category: International Medicine & Public Health Authors: Erica Reeve, Anne Marie Thow, Colin Bell, Katrin Engelhardt, Ella Cecilia Gamolo-Naliponguit, John Juliard Go and Gary Sacks Tags: Research Source Type: research

Top 10 Mesothelioma and Asbestos News Stories of 2020
Growing allegations of asbestos-contaminated talc in various consumer products, coupled with historic approval of a new treatment for pleural mesothelioma, made 2020 a year filled with both anxiety and hope. Johnson & Johnson stopped selling its iconic baby powder in May after being hit by thousands of lawsuits contending its talc-based product was causing various cancers, including ovarian cancer and malignant mesothelioma. The U.S. Food and Drug Administration approved the immunotherapy combination of Opdivo and Yervoy in October, the first new drug regimen approved for first-line treatment of unresectable disease in...
Source: Asbestos and Mesothelioma News - December 15, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more diffic...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news

Telehealth coordinators in hospital based telehealth services: Who are they and what do they do?
This study aimed to examine the key functions of telehealth coordinators in the Queensland public health system, their perceptions about their role, and the level of competencies to support this role. All telehealth coordinators within Queensland Health Telehealth Services were invited to complete a questionnaire. We collected: (i) demographic information; (ii) details of their telehealth work; and (iii) information about knowledge and skills relevant to their telehealth coordinator role. Eighteen of 20 (90%) participants completed and submitted the survey. Telehealth coordinators were responsible for a range of tasks rela...
Source: Journal of Telemedicine and Telecare - October 29, 2016 Category: Information Technology Authors: Edirippulige, S., Armfield, N. R., Greenup, P., Bryett, A. Tags: Special Issue - SFT 2016 Source Type: research

Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use
Publication date: August 2017 Source:Social Science &amp; Medicine, Volume 186 Author(s): Kelly R. Knight, Margot Kushel, Jamie S. Chang, Kara Zamora, Rachel Ceasar, Emily Hurstak, Christine Miaskowski There is growing concern among US-based clinicians, patients, policy makers, and in the media about the personal and community health risks associated with opioids. Perceptions about the efficacy and appropriateness of opioids for the management of chronic non-cancer pain (CNCP) have dramatically transformed in recent decades. Yet, there is very little social scientific research identifying the factors that have informe...
Source: Social Science and Medicine - June 9, 2017 Category: Psychiatry & Psychology Source Type: research

FDA Cautions Cancer Patients About Medical Marijuana
The U.S. Food and Drug Administration (FDA) issued a stern warning Wednesday to companies marketing medical marijuana to cure or inhibit cancer — including mesothelioma — and cautioned patients about unsubstantiated claims. The FDA sent warning letters to four particular companies, citing deceptive marketing in violation of the Federal Food, Drug and Cosmetic Act. “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer,” said FDA Commissioner Scott Gottlieb in a press release Wednesday. “And we’re not going to look the o...
Source: Asbestos and Mesothelioma News - November 2, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: FDA marijuana warning marijuana for cancer medical marijuana for cancer Source Type: news

Do Dutch news reports about suicide refer to suicide prevention strategies? - van Leeuwen L, Bommel é J.
Background: Previous research and media guidelines suggest two potential protective characteristics of news reports about suicide: (1) individuals who adopt coping strategies other than suicidal behavior are described and (2) information about resources...
Source: SafetyLit - August 19, 2019 Category: International Medicine & Public Health Tags: Media, Marketing, and Internet Issues Source Type: news